Home / News / News and Innovation / Kexing Biopharm...

Kexing Biopharm's Product List (FDA and EMA Approved)

Article source：Kexing Biopharm

Jun 17,2025

View： 2214

Kexing Biopharm's Product List (FDA and EMA Approved)

Kexing Biopharm's Product List (FDA and EMA Approved)

LABEL:

Related News

Kexing Biopharm Granted Exclusive Commercialization License for Overseas Marketing of TOT BIOPHARM's Bevacizumab

Kexing Biopharm Granted Exclusive Commercialization License for Overseas Marketing of TOT BIOPHARM's Bevacizumab

Kexing Biopharm Obtained Clinical Trial Approval for its Self-developed Class I Innovative Drug--Long-acting Growth Hormone

Kexing Biopharm Obtained Clinical Trial Approval for its Self-developed Class I Innovative Drug--Long-acting Growth Hormone

The signing & opening ceremony of "Kexing Biopharm - Southeast University Innovation Laboratory for Commercial ...

The signing & opening ceremony of "Kexing Biopharm - Southeast University Innovation Laboratory for Commercial ...

Kexing Biopharm obtained the products of Trastuzumab and Neratinib Maleate Tablets

Kexing Biopharm obtained the products of Trastuzumab and Neratinib Maleate Tablets

Shanghai Securities News' "Innovation China" visits Kexing Biopharm

Shanghai Securities News' "Innovation China" visits Kexing Biopharm

Kexing Biopharm's Completion of the First Dose of Its Long-acting GC Product in Subjects in Phase 1 Clinical Study for In-depth Layout of WBC-Stimulating Drug Market

Kexing Biopharm's Completion of the First Dose of Its Long-acting GC Product in Subjects in Phase 1 Clinical Study for In-depth Layout of WBC-Stimulating Drug Market